Cargando…

1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2

Detalles Bibliográficos
Autores principales: Jay, C., Stanbery, L., Kerneis, F., Nemunaitis, J., Aaron, P., Manning, L., Wallraven, G., Shanahan, D., Shen, Y., Senzer, N., Bognar, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506394/
http://dx.doi.org/10.1016/j.annonc.2020.08.1780
_version_ 1783585008453156864
author Jay, C.
Stanbery, L.
Kerneis, F.
Nemunaitis, J.
Aaron, P.
Manning, L.
Wallraven, G.
Shanahan, D.
Shen, Y.
Senzer, N.
Bognar, E.
author_facet Jay, C.
Stanbery, L.
Kerneis, F.
Nemunaitis, J.
Aaron, P.
Manning, L.
Wallraven, G.
Shanahan, D.
Shen, Y.
Senzer, N.
Bognar, E.
author_sort Jay, C.
collection PubMed
description
format Online
Article
Text
id pubmed-7506394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75063942020-09-23 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2 Jay, C. Stanbery, L. Kerneis, F. Nemunaitis, J. Aaron, P. Manning, L. Wallraven, G. Shanahan, D. Shen, Y. Senzer, N. Bognar, E. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506394/ http://dx.doi.org/10.1016/j.annonc.2020.08.1780 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jay, C.
Stanbery, L.
Kerneis, F.
Nemunaitis, J.
Aaron, P.
Manning, L.
Wallraven, G.
Shanahan, D.
Shen, Y.
Senzer, N.
Bognar, E.
1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title_full 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title_fullStr 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title_full_unstemmed 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title_short 1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
title_sort 1716p vigil plasmid (vp), a dual bi-shrna-furin/gmcsf construct from cancer to sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506394/
http://dx.doi.org/10.1016/j.annonc.2020.08.1780
work_keys_str_mv AT jayc 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT stanberyl 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT kerneisf 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT nemunaitisj 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT aaronp 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT manningl 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT wallraveng 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT shanahand 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT sheny 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT senzern 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2
AT bognare 1716pvigilplasmidvpadualbishrnafuringmcsfconstructfromcancertosarscov2